A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B
This study is looking into the long-term safety and tolerability of a treatment called SAR421869 for people living with Usher syndrome Type 1B. Usher syndrome affects hearing, balance, and vision. This particular study is for individuals who have already received SAR421869 as part of a previous research project. Researchers want to see if the treatment continues to be safe over a long period and if it has any lasting effects on the body. This is a follow-up study that could last for up to 15 years, involving assessments like blood tests to monitor participants' health and the treatment's impact.
En un coup d'œil
De quoi parle cette étude ?
This study is about a treatment called SAR421869 for a condition called Usher syndrome Type 1B. Usher syndrome is a rare genetic condition that usually affects a person's hearing, balance, and vision. There are different types, and Type 1B is one of them.
The main goal of this research is to see how safe this treatment is over a long time for people who have Usher syndrome Type 1B. Researchers also want to understand if the treatment has any lasting effects on the body. This study is aimed at people who have already taken part in a previous study where they received SAR421869. Think of it as a follow-up to check how they're doing years later.
By carefully watching how people respond to the treatment over a long period, doctors hope to learn more about its safety and if it has any positive impact on the condition. This information is really important for developing new and effective treatments for Usher syndrome Type 1B in the future.
Points clés
- This study is a long-term follow-up, up to 15 years.
- It's for people with Usher syndrome Type 1B who previously received SAR421869.
- The main goal is to check the long-term safety and whether the treatment is still having an effect.
- Participation involves health check-ups and giving blood samples.
- This study will help doctors learn more about Usher syndrome Type 1B treatments.
Qui peut être éligible ?
This study is specifically for adults, aged 18 years and older, who have Usher syndrome Type 1B. If you are interested, you must have already participated in another study called TDU13600. During that previous study, you would have received the SAR421869 treatment as an injection into your eye.
To join this study, you also need to be able to understand and sign a consent form. This form explains all the details of the study, and by signing it, you agree to take part. It's a way to make sure you have all the information and are happy to be involved.
If you did not receive the SAR421869 treatment in the previous TDU13600 study, then you would not be able to join this particular long-term follow-up research.
Cet étude pourrait-elle vous convenir ?
Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.
- Avez-vous 18 ans ou plus ?
- Do you have Usher syndrome Type 1B?
- Did you take part in a previous study called TDU13600?
- Did you receive the SAR421869 treatment in that previous study?
- Êtes-vous capable de comprendre et de signer un formulaire de consentement ?
En quoi consiste la participation ?
If you decide to take part in this study, you will be monitored for a long time, potentially up to 15 years. You'll have regular visits to the clinic where doctors and nurses will check your health. One of the main things you can expect is to have blood samples taken. These blood tests help the researchers understand how the SAR421869 treatment is affecting your body over time and to make sure you remain safe. While the specific number of visits isn't detailed, they will be spread out over many years to track the long-term effects. You won't receive the SAR421869 treatment again in this study; it's purely to observe those who received it previously.
Risques et avantages potentiels
Emplacements (2)
- Oregon Health and Science University Site Number : 840001Code postal vérifiéPortland, États-Unis
- Investigational Site Number : 250001Code postal vérifiéParis, France
Questions fréquentes
What is Usher syndrome Type 1B?
Usher syndrome Type 1B is a genetic condition that affects hearing, balance, and vision. It's rare and can vary in how it affects people.
What is SAR421869?
SAR421869 is a treatment that was given to participants in a previous study for Usher syndrome Type 1B. This study is now checking its long-term effects.
How long will I be in this study?
This study could last for a very long time, up to 15 years. It's designed for long-term monitoring.
Que devrai-je faire si je rejoins ?
You'll have regular check-ups and provide blood samples. These are to help researchers understand the long-term safety and effects of the treatment you received previously.
Will I get money for participating?
The information provided here doesn't mention payment for participation, but you should always ask the study team about any expenses or payments.
Comment en savoir plus
Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.
Discussion
Discussion communautaire
Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.